Table 3 Analysis of viral blips in animals with low viremia during tenofovir treatment and after tenofovir withdrawal
| Â | During tenofovir treatment | After tenofovir withdrawal | Â | ||||||
|---|---|---|---|---|---|---|---|---|---|
Animal numbera | Time window (weeks of infection)b | Number of time points for plasma viral RNA analysis | Number of time points with plasma viral RNA ≥ 50 copies per ml | Peak plasma virus copies per ml (time point) | Time window (weeks of infection)b | Number of time points for plasma viral RNA analysis | Number of time points with plasma viral RNA ≥ 50 copies per ml | Peak plasma virus copies per ml (time point) | One-sided p value for frequency of viremia ≥ 50 copies/ml during versus after tenofovir treatment |
29276c | 598-736 | 16 | 0 | NAc | NAc | NAc | NAc | NAc | NAc |
30577 | 299-552 | 39 | 12 | 270 (513 wks) | 553-595 wks | 40 | 7 | 1,100 (556 wks) | p = 0.13 |
32186 | 316-457 | 39 | 4 | 300 (418 wks) | 458 -498 wks | 40 | 9 | 3,600 (494 wks) | p = 0.13 |
33088 | 284-425 | 38 | 2 | 200 (386 wks) | 426-468 wks | 40 | 0 | 30 (435 wks) | p = 0.23 |